Drug Shortage Report for CLADRIBINE INJECTION
| Report ID | 127210 |
| Drug Identification Number | 02319918 |
| Brand name | CLADRIBINE INJECTION |
| Common or Proper name | Cladribine Injection |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | CLADRIBINE |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | mg/mL SD Vial, 10 mL |
| ATC code | L01BB |
| ATC description | ANTIMETABOLITES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-10-30 |
| Actual start date | |
| Estimated end date | 2020-11-16 |
| Actual end date | 2020-11-16 |
| Shortage status | Resolved |
| Updated date | 2021-01-26 |
| Company comments | Fresenius Kabi Canada Ltd. regrets to advise that due to a delay in shipment, we will be encountering a supply interruption on our Cladribine Injection, 1 mg/mL SD Vial, 10 mL. Please note the product will remain on 100% allocation until stock is depleted. UPDATE Fresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of our Cladribine Injection, 1 mg/mL, SD Vial, 10 mL have been released and will be available at all distribution centers across the country early next week November 16, 2020 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2021-01-26 | French | Compare |
| v4 | 2021-01-26 | English | Compare |
| v3 | 2020-10-31 | English | Compare |
| v2 | 2020-10-27 | French | Compare |
| v1 | 2020-10-27 | English | Compare |
Showing 1 to 5 of 5